Literature DB >> 2424992

Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes.

J Böhme, B Carlsson, J Wallin, E Möller, B Persson, P A Peterson, L Rask.   

Abstract

Insulin-dependent diabetes is generally associated with the serologic HLA-DR specificities 3 and 4, in particular with DR-3,4 heterozygosity. The disease is negatively associated with DR-2. To investigate these associations further at the genomic level, DNA from 13 families with a proband having insulin-dependent diabetes, from 11 other individuals with the same disease, and from HLA-DR-matched control individuals was subjected to restriction fragment analysis. Three different enzymes (Bam HI, Eco RI, and Pvu II) and cDNA clones for three HLA-D region class II antigen alpha- and beta-chains (DR-beta, DQ-beta, and DQ-alpha) were used. In six families, a total of 11 siblings HLA-DR-identical to the proband were examined. There was no discrepancy between the hybridization patterns of the proband and those of the DR-identical siblings. Two different DQ-B fragment patterns were detected with each one of the serologic specificities DR-2 and DR-4. In both cases, only one of the patterns correlated significantly with diabetes. Thus, DQ-beta genomic hybridization may be used in conjunction with HLA-DR typing to identify individuals with higher relative risk to acquire insulin-dependent diabetes. These results may suggest that insulin-dependent diabetes is associated with the DQ rather than with the DR locus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424992

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  Genetic analysis of susceptibility to type 1 diabetes.

Authors:  J A Todd
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes.

Authors:  J Fletcher; C Mijovic; O Odugbesan; D Jenkins; A R Bradwell; A H Barnett
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

3.  HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes.

Authors:  G Sterkers; D Zeliszewski; A M Chaussée; I Deschamps; M P Font; C Freidel; J Hors; H Betuel; J Dausset; J P Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.

Authors:  I Khalil; L d'Auriol; M Gobet; L Morin; V Lepage; I Deschamps; M S Park; L Degos; F Galibert; J Hors
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.

Authors:  M J Sheehy; S J Scharf; J R Rowe; M H Neme de Gimenez; L M Meske; H A Erlich; B S Nepom
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  The genetics of diabetes: from nightmare to headache.

Authors:  H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-11

7.  Allergic contact dermatitis to nickel is associated with a Taq I HLA-DQA allelic restriction fragment.

Authors:  O Olerup; L Emtestam
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

8.  Oligonucleotide probes for HLA-DQA and DQB genes define susceptibility to type 1 (insulin-dependent) diabetes mellitus.

Authors:  D Owerbach; S Gunn; G Ty; L Wible; K H Gabbay
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

9.  The HLA-D associations of type 1 (insulin-dependent) diabetes in Punjabi Asians in the United Kingdom.

Authors:  O Odugbesan; J Fletcher; C Mijovic; E Mackay; A R Bradwell; A H Barnett
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

10.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Authors:  P A Morel; J S Dorman; J A Todd; H O McDevitt; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.